The American Journal of Medicine
Volume 76, Issue 6 , Pages 983-988, June 1984

Prognostic significance of isolated sinus tachycardia during first three days of acute myocardial infarction

  • Allen Crimm, M.D.

      Affiliations

    • From the Department of Medicine, Duke University Medical Center, Durham, North Carolina.
    • Current address: Pennsylvania Hospital, 700 Spruce Street, Philadelphia, Pennsylvania 19106.
  • ,
  • Harry W. Severance Jr., M.D.

      Affiliations

    • From the Department of Medicine, Duke University Medical Center, Durham, North Carolina.
    • Current address: Department of Medicine, East Carolina University, Greenville, North Carolina.
  • ,
  • Kathy Coffey, B.S.

      Affiliations

    • From the Department of Medicine, Duke University Medical Center, Durham, North Carolina.
  • ,
  • Ray Mckinnis, Ph.D.

      Affiliations

    • From the Department of Medicine, Duke University Medical Center, Durham, North Carolina.
  • ,
  • Galen S. Wagner, M.D.

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to Dr. Galen S. Wagner, P.O. Box 31211, Duke University Medical Center, Durham, North Carolina 27710.
    • From the Department of Medicine, Duke University Medical Center, Durham, North Carolina.
  • ,
  • Robert M. Califf, M.D.

      Affiliations

    • From the Department of Medicine, Duke University Medical Center, Durham, North Carolina.

Durham, North Carolina USA

Accepted 22 November 1983.

Abstract 

Sinus tachycardia often accompanies other indicators of poor prognosis in acute myocardial infarction. This study was performed to evaluate the prognostic significance of early (Days 1 to 3) inhospital sinus tachycardia (isolated sinus tachycardia) in the absence of other common indicators of poor prognosis. All patients consecutively admitted directly to the cardiac care unit during a six-year period were evaluated. Patients who had confirmed acute myocardial infarction and no urgent complications during Days 1 to 3 with isolated sinus tachycardia (99 patients) or without isolated sinus tachycardia (159 patients) were included in the study. Both groups were followed for subsequent in-hospital outcome and long-term survival. Univariable and multivariable analysis of historical and demographic characteristics showed no significant differences between the two groups. When clinical descriptors of the infarct were evaluated, the group with isolated sinus tachycardia had a significantly higher mean peak creatine kinase level (p = 0.0007), a larger proportion of anterior infarcts and multiple infarct sites (p < 0.001) by electrocardiography, a higher incidence of peri-infarction pericarditis (p = 0.007), and a higher incidence of recurrent chest pain (p = 0.03). Twenty-five patients (25 percent) in the group with isolated sinus tachycardia had subsequent urgent complications during the hospitalization compared with 11 patients (7 percent) in the control group (p = 0.00005). In multivariable analysis, isolated sinus tachycardia was an independent predictor of subsequent urgent complications (p = 0.0009) and mortality (p = 0.05).

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This work was supported in part by Research Grant HS-03834 from the National Center for Health Services Research and the National Center for Health Care Technology, by Research Grant HL-17670 from the National Heart, Lung, and Blood Institute, and by grants from the Prudential Insurance Company of America, the Kaiser Family Foundation, and the Andrew W. Mellon Foundation.

PII: 0002-9343(84)90846-5

The American Journal of Medicine
Volume 76, Issue 6 , Pages 983-988, June 1984